Recent clinical data, specifically from the VITAL (Vitamin D and Omega-3 Trial) sub-study published in 2025, has provided some of the most robust evidence to date regarding the relationship between vitamin D and telomeres.
While previous research was mostly observational, this randomized controlled trial (RCT) tracked over 1,000 participants over four years to measure actual telomere attrition (the rate at which they shorten).
Key Study Findings (2025 VITAL Trial)
Reduced Attrition: Participants taking 2,000 IU of Vitamin D3 daily showed significantly less telomere shortening compared to the placebo group.
Biological Aging: The study concluded that the vitamin D group reduced their telomere attrition by approximately 140 base pairs over four years. This is roughly equivalent to preventing three years of biological aging.
Omega-3 Contrast: Interestingly, the same study found that Omega-3 fatty acid supplementation had no significant effect on telomere length, suggesting the anti-aging benefit was specific to vitamin D.
Telomerase Activity: Earlier smaller studies (such as those involving overweight adults) suggested that vitamin D may work by increasing the activity of telomerase, the enzyme responsible for maintaining and repairing the ends of chromosomes
No comments:
Post a Comment